New Imaging-derived Biomarkers Based on Tridimensional CTA/MRI Hybrid Models for Complex Assessment of Myocardial Viability after Myocardial Infarction – the HYBRIDHEART Study

1. WHO. The global burden of disease: 2004 update. Geneva: World Health Organization; 2008b. Available at: http://www.who.int/healthinfo/global_burden_disease/2004_report_update/en/Search in Google Scholar

2. Saeed M, Van TA, Krug R, Hetts SW, Wilson MW. Cardiac MR Imaging: Current Status and Future Direction. Cardiovasc Diagn Ther. 2015;5:290-310.Search in Google Scholar

3. Dreyer RP, Wang Y, Strait KM, et al. Gender differences in the trajectory of recovery in health status among young patients with acute myocardial infarction: results from the variation in recovery: role of gender on outcomes of young AMI patients (VIRGO) study. Circulation. 2015;131:1971.10.1161/CIRCULATIONAHA.114.014503465772925862743Search in Google Scholar

4. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581-98.10.1016/j.jacc.2012.08.00122958960Search in Google Scholar

5. Lloyd-Jones DM, Larson MG, Leip EP, et al. Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068-3072.10.1161/01.CIR.0000039105.49749.6F12473553Search in Google Scholar

6. Smith SC Jr, Blair SN, Bonow RO, et al. AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 2001;104:1577-1579.10.1161/hc3801.09747511571256Search in Google Scholar

7. Steg PG, Dabbous OH, Feldman LJ, et al. Determinants and prognostic impact of heart failure complicating acute coronary syndromes: observations from the Global Registry of Acute Coronary Events (GRACE). Circulation. 2004;109:494-499.10.1161/01.CIR.0000109691.16944.DA14744970Search in Google Scholar

8. Sutton MG, Sharpe N. Left ventricular remodeling after myocardial infarction: pathophysiology and therapy. Circulation. 2000;101:2981-2988.10.1161/01.CIR.101.25.2981Search in Google Scholar

9. Jernberg T, Johanson P, Held C, et al. Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction. JAMA. 2011;305:1677-1684.10.1001/jama.2011.52221521849Search in Google Scholar

10. Gale CP, Allan V, Cattle BA, et al. Trends in hospital treatments, including revascularisation, following acute myocardial infarction, 2003–2010: a multilevel and relative survival analysis for the National Institute for Cardiovascular Outcomes Research (NICOR). Heart. 2014;100:582-589.10.1136/heartjnl-2013-30451724436220Search in Google Scholar

11. Koukkunen H, Penttilä K, Kemppainen A, Halinen M, Penttilä I, Rantanen T, Pyörälä K. C-reactive protein, fibrinogen, interleukin-6 and tumour necrosis factor-α in the prognostic classification of unstable angina pectoris. Ann Med. 2001;1;33:37-47.10.3109/0785389010900205811310937Search in Google Scholar

12. Sano T, Tanaka A, Namba M, et al. C-reactive protein and lesion morphology in patients with acute myocardial infarction. Circulation. 2003;108:282-285.10.1161/01.CIR.0000079173.84669.4F12835218Search in Google Scholar

13. Kohchi K, Takebayashi S, Hiroki T, et al. Significance of adventitial inflammation of the coronary artery in patients with unstable angina: results at autopsy. Circulation. 1985;71:709-716.10.1161/01.CIR.71.4.709Search in Google Scholar

14. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 1990;81:1161-1172.10.1161/01.CIR.81.4.1161Search in Google Scholar

15. Chatterjee K, Swan HJ, Parmley WW, Sustaita H, Marcus HS, Matloff J. Influence of direct myocardial revascularization on left ventricular asynergy and function in patient with coronary heart disease with and without previous myocardial infarction. Circulation. 1973;47:276-286.10.1161/01.CIR.47.2.2764684928Search in Google Scholar

16. Wijns W, Vatner SF, Camici PG. Hibernating myocardium. N Engl J Med. 1998;339:173-181.10.1056/NEJM1998071633903079664095Search in Google Scholar

17. Partington SL, Kwong RY, Dorbala S. Multimodality imaging in the assessment of myocardial viability. Heart Fail Rev. 2011;16:381.10.1007/s10741-010-9201-7395452021069458Search in Google Scholar

18. Stănescu A, Opincariu D, Rat N, et al. Hybrid Imaging in the Assessment of Myocardial Ischemia and Viability. Journal of Interdisciplinary Medicine. 2016;3:242-246.10.1515/jim-2016-0071Search in Google Scholar

19. Masuda A, Yamaki T, Kunii H, et al. Simultaneous Assessment of Myocardial Viability With 18F-fluorodeoxyglucose Uptake and Late Gadolinium Enhancement by PET/MRI. Circulation. 2016;134:A11929.Search in Google Scholar

20. Danad I, Raijmakers PG, Appelman YE, et al. Hybrid imaging using quantitative H2 15O PET and CT-based coronary angiography for the detection of coronary artery disease. J Nucl Med. 2013;54:55-63.10.2967/jnumed.112.10468723232274Search in Google Scholar

21. Kajander S, Joutsiniemi E, Saraste M, et al. Cardiac positron emission tomography/computed tomography imaging accurately detects anatomically and functionally significant coronary artery disease. Circulation. 2010;122:603-613.10.1161/CIRCULATIONAHA.109.91500920660808Search in Google Scholar

22. Rispler S, Keidar Z, Ghersin E, et al. Integrated single-photon emission computed tomography and computed tomography coronary angiography for the assessment of hemodynamically significant coronary artery lesions. J Am Coll Cardiol. 2007;49:1059-1067.10.1016/j.jacc.2006.10.06917349885Search in Google Scholar